Utah mom fights for her daughter's access to discontinued diabetes medication: ‘Life-saving' [FOX News]
Novo Nordisk A/S (NVO)
Last novo nordisk a/s earnings: 2/5 01:31 am
Check Earnings Report
US:NYSE Investor Relations:
novonordisk.com/investors.html
Company Research
Source: FOX News
A Utah mother is fighting for her teenage daughter's access to diabetes medicine. Ruby Smart, 15, has been taking Levemir (detemir) insulin since she was diagnosed with type 1 diabetes more than two years ago. "Levemir is uniquely suited to her situation," Alison Smart, the girl's mother, told Fox News Digital in an interview. The family was stunned when Novo Nordisk, the Denmark-based manufacturer of Levemir, announced in November 2023 that the drug was being discontinued. Smart has now made it her mission to convince Novo Nordisk to continue making Levemir — or to find a pharmaceutical company to create a biosimilar (generic) alternative. Levemir is a long-acting basal insulin that's injected once or twice a day to control high blood sugar in adults and children with diabetes, according to Novo Nordisk's website. For Smart's daughter, an active athlete who plays on the tennis team at Woods Cross High School, Levemir has enabled her to continue with her regular activitie
Show less
Read more
Impact Snapshot
Event Time:
NVO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVO alerts
High impacting Novo Nordisk A/S news events
Weekly update
A roundup of the hottest topics
NVO
News
- UK's FTSE 100 Edges Lower in Thin Trading Ahead of Fed Decision [BNN Bloomberg (Canada)]BNN Bloomberg
- Denmark, home of Ozempic, feels the drug's effects [Yahoo! Finance]Yahoo! Finance
- Amgen Q1 Earnings Preview: Obesity treatment updates to be the focus this season [Seeking Alpha]Seeking Alpha
- Amgen investors await weight-loss drug data [Yahoo! Finance]Yahoo! Finance
- Amgen investors await weight-loss drug data [Reuters]Reuters
NVO
Earnings
- 11/3/23 - Beat
NVO
Sec Filings
- 5/1/24 - Form 6-K
- 4/26/24 - Form 6-K
- 4/25/24 - Form 6-K
- NVO's page on the SEC website